Optivia Biotechnology

San Francisco, United States Founded: 2007 • Age: 19 yrs Acquired By BioIVT
CRO offering transporter screening services and solutions for DDI, DMPK, safety and pharmacology

About Optivia Biotechnology

Optivia Biotechnology is a company based in San Francisco (United States) founded in 2007 was acquired by BioIVT in July 2018.. Optivia Biotechnology operates in a competitive market with competitors including Anabios, Metrion Biosciences, Quiver Bioscience, Zen-Bio and Rules-Based Medicine, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.85 M (USD), Grant

    Mar 31, 2011

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    BioIVT

    (Jul 09, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Optivia Biotechnology

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $1.8M
  • First Round

    (22 Jan 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2011 Amount Grant - Optivia Biotechnology Valuation

investors

HHS
May, 2010 Amount Grant - Optivia Biotechnology Valuation

investors

HHS
Jan, 2009 Amount Grant - Optivia Biotechnology Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Optivia Biotechnology

Optivia Biotechnology has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and BioIVT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Provider of in vitro diagnostic products and assay services
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Optivia Biotechnology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Optivia Biotechnology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Optivia Biotechnology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Optivia Biotechnology

Optivia Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Metrion Biosciences, Quiver Bioscience, Zen-Bio and Rules-Based Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Ex-vivo human tissue studies are performed for preclinical drug discovery.
domain founded_year HQ Location
Ion channel screening and cardiac safety profiling services are provided.
domain founded_year HQ Location
Developer of transformational medicines for neurological disorders
domain founded_year HQ Location
Cell-based solutions are provided to accelerate therapy discovery and development.
domain founded_year HQ Location
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
domain founded_year HQ Location
Cardiac safety testing is conducted using iPS-derived heart cells.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Optivia Biotechnology

Frequently Asked Questions about Optivia Biotechnology

When was Optivia Biotechnology founded?

Optivia Biotechnology was founded in 2007 and raised its 1st funding round 2 years after it was founded.

Where is Optivia Biotechnology located?

Optivia Biotechnology is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

What does Optivia Biotechnology do?

Optivia Biotechnology was founded in 2007 in San Francisco, United States, as a contract research organization in the biotechnology sector. Transporter-related assay services, informatics products, and customized solutions are offered for drug-drug interaction (DDI), drug metabolism and pharmacokinetics (DMPK), safety, and pharmacology studies. These services support biotechnology, pharmaceutical, and academic organizations through predictive screening and research tools.

Who are the top competitors of Optivia Biotechnology?

Optivia Biotechnology's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.

Who are Optivia Biotechnology's investors?

Optivia Biotechnology has 2 investors. Key investors include HHS, and BioIVT.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available